Imaging Registry Begins: Coverage-With-Evidence Policy Gets A Second Wind
This article was originally published in The Gray Sheet
Executive Summary
The May 8 commencement of a nationwide positron emission tomography imaging registry is an important step forward for CMS' fledgling coverage-with-evidence-development (CED) policy, not to mention for expanded use of PET scans
You may also be interested in...
CMS Unconvinced On PET Scans For Bone Metastasis; CED Data Not Enough
While National Oncologic PET Registry data has been effective in persuading CMS to remove evidence-development restrictions from positron emission tomography coverage policies in the past, NOPR data was not enough to support coverage of PET scans to identify bone metastasis in a Dec. 15 national coverage determination.
Informed Consent Debate Resurfaces Over Medicare Coverage With Evidence Development
The debate over whether informed consent is necessary and whether it can be valid in the context of Medicare coverage-with-evidence-development determinations came up in public comments to CMS on its pending national coverage policy for transcatheter aortic valve replacement.
CMS Reconsiders Data Collection Requirements For Oncologic PET Scans
CMS will consider a request to lift its registry-enrollment requirements for positron emission tomography scans for certain cancers, the agency said April 10